Arbutus Loses Key European Patent in Moderna Dispute
Arbutus Biopharma shares dropped 16% after losing European patent dispute with Moderna. The biotech plans to appeal the ruling that affects ongoing litigation.
Arbutus Biopharma shares dropped 16% after losing European patent dispute with Moderna. The biotech plans to appeal the ruling that affects ongoing litigation.
Trump administration and Northeast governors plan emergency PJM auction forcing tech companies to fund $15B in new power plants for AI data centers, protecting consumers from rising electricity bills.
Riot Platforms acquires 200-acre Texas site and signs $311M data center lease with AMD, marking pivot from Bitcoin mining to AI infrastructure with potential $1B revenue.
Benchmark raises Dave & Buster’s stock to Buy, citing stronger food, drinks, and Half Price Games promotion for Q1 growth.
Mosaic shares dropped 5% after reporting weaker-than-expected Q4 fertilizer demand. Company sees improvement ahead with spring demand and Chinese export restrictions supporting 2026 outlook.
Goldman Sachs raises BioNTech to Buy, citing its strong position in oncology and upcoming 2026 data that could boost new cancer therapies.